Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosis

Background: Cardiovascular comorbidities are frequent in patients with idiopathic pulmonary fibrosis (IPF), and many patients with IPF receive treatment with statins to reduce cardiovascular risk. Objectives: We investigated whether statin use at baseline was associated with differences in disease p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kreuter, Michael (VerfasserIn) , Costabel, Ulrich (VerfasserIn) , Richeldi, Luca (VerfasserIn) , Cottin, Vincent (VerfasserIn) , Wijsenbeek, Marlies (VerfasserIn) , Bonella, Francesco (VerfasserIn) , Bendstrup, Elisabeth (VerfasserIn) , Maher, Toby M. (VerfasserIn) , Wachtlin, Daniel (VerfasserIn) , Stowasser, Susanne (VerfasserIn) , Kolb, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 07, 2018
In: Respiration
Year: 2018, Jahrgang: 95, Heft: 5, Pages: 317-326
ISSN:1423-0356
DOI:10.1159/000486286
Online-Zugang:Verlag, Volltext: https://doi.org/10.1159/000486286
Verlag: https://www.karger.com/Article/FullText/486286
Volltext
Verfasserangaben:Michael Kreuter, Ulrich Costabel, Luca Richeldi, Vincent Cottin, Marlies Wijsenbeek, Francesco Bonella, Elisabeth Bendstrup, Toby M. Maher, Daniel Wachtlin, Susanne Stowasser, Martin Kolb

MARC

LEADER 00000caa a2200000 c 4500
001 1680555138
003 DE-627
005 20251023100205.0
007 cr uuu---uuuuu
008 191029s2018 xx |||||o 00| ||eng c
024 7 |a 10.1159/000486286  |2 doi 
035 |a (DE-627)1680555138 
035 |a (DE-599)KXP1680555138 
035 |a (OCoLC)1341249408 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kreuter, Michael  |d 1972-  |e VerfasserIn  |0 (DE-588)122645995  |0 (DE-627)082066795  |0 (DE-576)293362742  |4 aut 
245 1 0 |a Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosis  |c Michael Kreuter, Ulrich Costabel, Luca Richeldi, Vincent Cottin, Marlies Wijsenbeek, Francesco Bonella, Elisabeth Bendstrup, Toby M. Maher, Daniel Wachtlin, Susanne Stowasser, Martin Kolb 
264 1 |c February 07, 2018 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.10.2019 
520 |a Background: Cardiovascular comorbidities are frequent in patients with idiopathic pulmonary fibrosis (IPF), and many patients with IPF receive treatment with statins to reduce cardiovascular risk. Objectives: We investigated whether statin use at baseline was associated with differences in disease progression in placebo-treated patients or influenced the treatment effect of nintedanib in the INPULSIS® trials. Methods: Post-hoc subgroup analyses of patients receiving versus not receiving statins at baseline using pooled data from the INPULSIS® trials. Results: At baseline, 312 patients received statins and 749 did not. The annual rates of decline in forced vital capacity (FVC) in patients treated with nintedanib and placebo, respectively, were -78.9 and -187.6 mL/year in patients who received statins at baseline, and -127.9 and -237.9 mL/year in patients who did not. The effect of nintedanib was consistent across subgroups (p = 0.9590). Conclusions: In the INPULSIS® trials, there was a numerically lower FVC decline in placebo-treated patients with IPF who received statins at baseline versus those who did not. Use of statins at baseline did not influence the treatment effect of nintedanib. Prospective data are needed to assess the impact of statins on the course of IPF. 
700 1 |a Costabel, Ulrich  |d 1949-  |e VerfasserIn  |0 (DE-588)172658764  |0 (DE-627)697592340  |0 (DE-576)133517357  |4 aut 
700 1 |a Richeldi, Luca  |e VerfasserIn  |0 (DE-588)116026578X  |0 (DE-627)1023418843  |0 (DE-576)505817535  |4 aut 
700 1 |a Cottin, Vincent  |e VerfasserIn  |0 (DE-588)1160685010  |0 (DE-627)1024082911  |0 (DE-576)506122018  |4 aut 
700 1 |a Wijsenbeek, Marlies  |e VerfasserIn  |4 aut 
700 1 |a Bonella, Francesco  |e VerfasserIn  |0 (DE-588)1188737015  |0 (DE-627)166764534X  |4 aut 
700 1 |a Bendstrup, Elisabeth  |e VerfasserIn  |0 (DE-588)1189169967  |0 (DE-627)1667900641  |4 aut 
700 1 |a Maher, Toby M.  |e VerfasserIn  |0 (DE-588)1171342616  |0 (DE-627)1040485049  |0 (DE-576)513692673  |4 aut 
700 1 |a Wachtlin, Daniel  |e VerfasserIn  |4 aut 
700 1 |a Stowasser, Susanne  |e VerfasserIn  |4 aut 
700 1 |a Kolb, Martin  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Respiration  |d Basel : Karger, 1968  |g 95(2018), 5, Seite 317-326  |h Online-Ressource  |w (DE-627)26551035X  |w (DE-600)1464419-8  |w (DE-576)112815111  |x 1423-0356  |7 nnas  |a Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosis 
773 1 8 |g volume:95  |g year:2018  |g number:5  |g pages:317-326  |g extent:10  |a Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosis 
856 4 0 |u https://doi.org/10.1159/000486286  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.karger.com/Article/FullText/486286  |x Verlag 
951 |a AR 
992 |a 20191029 
993 |a Article 
994 |a 2018 
998 |g 122645995  |a Kreuter, Michael  |m 122645995:Kreuter, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PK122645995  |e 950000PK122645995  |e 950900PK122645995  |e 50000PK122645995  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1680555138  |e 3530840521 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Michael","display":"Kreuter, Michael","family":"Kreuter"},{"display":"Costabel, Ulrich","roleDisplay":"VerfasserIn","role":"aut","given":"Ulrich","family":"Costabel"},{"display":"Richeldi, Luca","given":"Luca","roleDisplay":"VerfasserIn","role":"aut","family":"Richeldi"},{"given":"Vincent","role":"aut","roleDisplay":"VerfasserIn","display":"Cottin, Vincent","family":"Cottin"},{"display":"Wijsenbeek, Marlies","roleDisplay":"VerfasserIn","role":"aut","given":"Marlies","family":"Wijsenbeek"},{"family":"Bonella","display":"Bonella, Francesco","given":"Francesco","role":"aut","roleDisplay":"VerfasserIn"},{"family":"Bendstrup","role":"aut","roleDisplay":"VerfasserIn","given":"Elisabeth","display":"Bendstrup, Elisabeth"},{"family":"Maher","display":"Maher, Toby M.","role":"aut","roleDisplay":"VerfasserIn","given":"Toby M."},{"family":"Wachtlin","given":"Daniel","roleDisplay":"VerfasserIn","role":"aut","display":"Wachtlin, Daniel"},{"display":"Stowasser, Susanne","given":"Susanne","role":"aut","roleDisplay":"VerfasserIn","family":"Stowasser"},{"family":"Kolb","roleDisplay":"VerfasserIn","role":"aut","given":"Martin","display":"Kolb, Martin"}],"language":["eng"],"name":{"displayForm":["Michael Kreuter, Ulrich Costabel, Luca Richeldi, Vincent Cottin, Marlies Wijsenbeek, Francesco Bonella, Elisabeth Bendstrup, Toby M. Maher, Daniel Wachtlin, Susanne Stowasser, Martin Kolb"]},"id":{"eki":["1680555138"],"doi":["10.1159/000486286"]},"origin":[{"dateIssuedDisp":"February 07, 2018","dateIssuedKey":"2018"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"id":{"issn":["1423-0356"],"zdb":["1464419-8"],"eki":["26551035X"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["Vol. 25, no. 1 (1968)-"],"part":{"pages":"317-326","extent":"10","year":"2018","text":"95(2018), 5, Seite 317-326","issue":"5","volume":"95"},"recId":"26551035X","note":["Gesehen am 03.07.2024"],"disp":"Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosisRespiration","language":["eng"],"origin":[{"dateIssuedDisp":"1968-","publisher":"Karger","dateIssuedKey":"1968","publisherPlace":"Basel"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"international journal of thoracic medicine","title_sort":"Respiration","title":"Respiration"}]}],"title":[{"title_sort":"Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosis","title":"Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosis"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 29.10.2019"],"recId":"1680555138"} 
SRT |a KREUTERMICSTATINTHER0720